drugset / Trial / NCT01615614
A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the pharmacokinetics of different dosing regimens of rilpivirine in combination with rifabutin in healthy participants.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifabutin | Small molecule | 150 mg | Oral |
| Subject | Rilpivirine | Small molecule | 25 mg | Oral |
| Subject | Rilpivirine | Small molecule | 50 mg | Oral |
Indications
No indication recorded.